anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
atai Life Sciences · pitchdeck

ATAI | Investor Presentation Deck | 33 slides

33 pages · 4 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

ATAI | Investor Presentation Deck | 33 slides

atai Life Sciences · 2023-01
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 8 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 2 slides 100% 2/2 slides 100% 2/2 slides · 15 hits
— 0/2 slides
— 0/2 slides
50% 1/2 slides 100% 2/2 slides · 3 hits
— 0/2 slides
Solution 2 slides 100% 2/2 slides 100% 2/2 slides · 12 hits
— 0/2 slides
— 0/2 slides
100% 2/2 slides 100% 2/2 slides · 3 hits
— 0/2 slides
Traction 2 slides 100% 2/2 slides 100% 2/2 slides · 12 hits
— 0/2 slides
— 0/2 slides
50% 1/2 slides 100% 2/2 slides · 3 hits
— 0/2 slides
Roadmap 2 slides 100% 2/2 slides 100% 2/2 slides · 10 hits
— 0/2 slides
— 0/2 slides
100% 2/2 slides 100% 2/2 slides · 3 hits
— 0/2 slides

Slide inventory

33
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
Includes a footer note specifying the date of the presentation as January 6th, 2023.other
Open slide detail
03
summarize
Open slide detail
04
Uses a hierarchical structure to break down the objective into three strategic pillars.present_solution
Open slide detailBeat · Solution
05
The slide uses a Gantt-style visualization to show the progress of drug development programs.plan_implementation
Open slide detailBeat · Solution
06
The slide uses a timeline framework to communicate both past achievements and future R&D milestones.plan_implementation
Open slide detailBeat · Roadmap
07
transition
Open slide detail
08
Uses a vertical timeline-style list to present the 'Huge Need for Development' metrics.frame_problem
Open slide detailBeat · Problem
09
Includes a quote from Keith Nuechterlein and specific Cohen's d effect size metrics.show_traction
Open slide detailBeat · Problem
10
The slide uses a vertical process flow to demonstrate clinical progression and de-risking.show_traction
Open slide detailBeat · Traction
11
The slide highlights the efficacy of RL-007 in cognitive endpoints during a Phase 2 study.show_traction
Open slide detail
12
The slide uses a standard clinical trial flow diagram to illustrate the study protocol.present_framework
Open slide detail
13
The slide uses a feature-comparison matrix to highlight the competitive advantage of RL-007.compare_peers
Open slide detail
14
transition
Open slide detail
15
The slide uses a split-layout: left side defines the disease and market size, right side outlines the clinical 'urgent need' for innovation.frame_problem
Open slide detailLoop · Cost Of Inaction
16
The slide uses a line chart to demonstrate the efficacy of different dosages of COMP360 over 12 weeks.show_traction
Open slide detailLoop · Cost Of Inaction
17
The slide uses a timeline-based process diagram to illustrate clinical trial protocols.plan_implementation
Open slide detail
18
The slide uses a split layout: a left-hand sidebar for product summary and a right-hand side for clinical data visualization.summarize
Open slide detail
19
The slide uses a dark sidebar for product specs and a white main area for trial design and results.summarize
Open slide detail
20
transition
Open slide detail
21
The slide uses a combination of a disease overview, market sizing metrics, and a 'massive unaddressed need' framework to justify the problem.frame_problem
Open slide detail
22
Includes a comparison chart of Etifoxine vs Lorazepam and a summary of Phase 1 trial design.summarize
Open slide detail
23
Includes detailed TEAE (Treatment-emergent Adverse Event) breakdown by dose cohort.analyze_data
Open slide detail
24
The slide uses topographical brain maps to visualize EEG data changes across three cohorts (Placebo, Low Dose, High Dose).show_traction
Open slide detail
25
The chart displays pharmacodynamic data with error bars and significance markers (asterisks).analyze_data
Open slide detail
26
The slide uses a checkmark matrix to highlight the competitive advantages of the proposed drug.compare_peers
Open slide detail
27
transition
Open slide detail
28
Uses a timeline-style visual to list key statistics about the OUD crisis.frame_problem
Open slide detail
29
Includes a line chart showing HCQN subscale scores over time and a two-stage clinical trial design diagram.summarize
Open slide detailLoop · Why Now
30
The slide uses a checkmark-based comparison matrix to highlight the unique value proposition of DMX-1002.compare_peers
Open slide detailLoop · Why Now
31
transition
Open slide detail
32
The slide uses a structured card-based layout to present four distinct business units.present_solution
Open slide detail
33
The slide uses a deep blue background with a subtle dot-pattern texture on the right side.inspire_vision
Open slide detail